Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jan 2;9(1):15. doi: 10.3390/antibiotics9010015

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Distribution of antibiotic resistance rates and profiles. S. maltophilia strains were evaluated for in vitro susceptibility to six antibiotics: SXT, cotrimoxazole; CHL, chloramphenicol; LVX, levofloxacin; CPX, ciprofloxacin; TZP, piperacillin/tazobactam; MER, meropenem. The frequencies of (A) antibiotic resistances, and (B) multiresistance profiles (non-MDR, MDR, XDR, and PDR) were calculated for cystic fibrosis (CF) (n = 40), non-CF (n = 45), and overall (n = 85) strains. (C) Resistance rates were calculated according to the capability to form biofilm: Non-producers (NP; n = 10) or biofilm-producers (n = 75; gathering strong, moderate, and weak-producers). Significance level at Fisher’s exact test: * p < 0.05; *** p < 0.001. Resistance profiles according to Magiorakos et al. [24]: MDR, multidrug-resistant strains; XDR, extensively drug-resistant strains; PDR, pandrug-resistant strains.